Page last updated: 2024-09-04

cinacalcet and Hypocalcemia

cinacalcet has been researched along with Hypocalcemia in 36 studies

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (27.78)29.6817
2010's22 (61.11)24.3611
2020's4 (11.11)2.80

Authors

AuthorsStudies
Carcaboso, AM; Ecker, RC; Garcia, M; Gómez-González, S; Gonçalves-Alves, E; Lavarino, C; Mateo-Lozano, S; Mora, J; Muñoz-Aznar, O; Rodríguez-Hernández, CJ; Suñol, M1
Fung, MM; Lang, BH; Lui, DT; Tam, DS1
Barreto, FC; Bucharles, SGE; Riella, MC1
Florakis, D; Karakozis, S; Makras, P; Tseleni-Balafouta, S1
Erhard, C; Floege, J; Fouqueray, B; Louie, KS; Stenvinkel, P; Wheeler, DC1
Del Vecchio, L; Locatelli, F; Mazzaferro, S; Rotondi, S1
Ohno, Y; Oshima, J; Otsuka, K1
Chertow, GM; Drueke, TB; Floege, J; Iles, J; Parfrey, P; Tsirtsonis, K1
Evenepoel, P; Shroff, R1
Ariceta, G; Dehmel, B; Hidalgo, G; Iles, JN; Jiang, X; Laskin, B; Schaefer, F; Shahinfar, S; Vande Walle, J; Warady, BA1
Chen, P; Gisleskog, PO; Melhem, M; Narayanan, A; Sohn, W1
Alexander, RT; Beggs, MR; Chen, XZ; Dimke, H; Flockerzi, V; Lee, JJ; Liu, X; O'Neill, D; Weissgerber, P1
Bleich, M; Gong, Y; Himmerkus, N; Hou, J; Plain, A1
Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y1
Ballarín, J; Bover, J; Cozzolino, M; daSilva, I; del Carpio, J; Lescano, P; Ruiz-García, C; Ureña, P1
Berliner, A; Jaar, BG; McMahon, BA; Novick, T1
Babinsky, VN; Gorvin, CM; Hannan, FM; Hanyaloglu, AC; Howles, SA; Hu, J; Nesbit, MA; Rust, N; Spiegel, AM; Thakker, RV1
Sane, DC1
Kalantar-Zadeh, K; Kovesdy, CP1
Cannata-Andía, JB; Fernández-Martín, JL1
Calvo, BF; Kim, HJ; Meyers, MO; Ollila, DW; Russell, CP; Yeh, JJ1
Burren, C; Dudley, J; Inward, C; McGraw, M; Platt, C; Saleem, MA; Tizard, J1
Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W1
Goltzman, D1
Ahlenstiel, T; Ariceta, G; Bak, M; Bakkaloglu, SA; Borzych, D; Chua, A; Ha, IS; Hari, P; Klaus, G; Lipka, M; Lopez, L; Ozaltin, F; Printza, N; Rees, L; Schaefer, F; Spizzirri, AP; Valles, PG; Vogel, A; Warady, BA; Yap, HK; Zambrano, P1
Bertrand, Q; Flamion, B; Loute, G; Pirson, Y; Simon, F1
Goretzki, PE; Lammers, BJ; Schwarz, K; Wirowski, D1
Block, GA; Chertow, GM; Correa-Rotter, R; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Mix, TC; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC1
Banti, C; Borretta, G; Brandi, ML; Cavalli, L; Cetani, F; Colao, A; Del Prete, M; Faggiano, A; Frasoldati, A; Gianotti, L; Grimaldi, F; Marcocci, C; Minisola, S; Papini, E; Romagnoli, E; Saponaro, F; Scillitani, A; Vescini, F1
Chrul, S; Zwiech, R1
Nagano, N1
Fournier, A; Harbouche, L; Monge, M; Shahapuni, I1
Nowack, R; Wachtler, P1
Aloisi, C; Buemi, M; Campo, S; Coppolino, G; Crascì, E; Nostro, L; Sturiale, A; Villari, A; Villari, I1
Antonelli, M; Basile, C; Giammaria, B; Lomonte, C; Losurdo, N; Marchio, G1

Reviews

2 review(s) available for cinacalcet and Hypocalcemia

ArticleYear
Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.
    Clinical journal of the American Society of Nephrology : CJASN, 2016, Jan-07, Volume: 11, Issue:1

    Topics: Calcimimetic Agents; Cinacalcet; Electrocardiography; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis; Vascular Calcification

2016
[Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion].
    Clinical calcium, 2005, Volume: 15, Issue:1

    Topics: Animals; Calcium; Cinacalcet; Clinical Trials as Topic; Depression, Chemical; Genes, Dominant; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Mutation; Naphthalenes; Parathyroid Hormone; Phosphorus; Rats; Receptors, Calcium-Sensing

2005

Trials

5 trial(s) available for cinacalcet and Hypocalcemia

ArticleYear
Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial.
    Kidney international, 2018, Volume: 93, Issue:6

    Topics: Adult; Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Incidence; Male; Middle Aged; Renal Dialysis; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome

2018
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis.
    Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:3

    Topics: Adolescent; Calcimimetic Agents; Calcium; Child; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Hypertension; Hypocalcemia; Male; Nausea; Parathyroid Hormone; Placebos; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D; Vomiting

2019
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 66, Issue:1

    Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Contraindications; Denosumab; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteoclasts; Prospective Studies; RANK Ligand; Renal Dialysis

2015
Middle-term use of Cinacalcet in paediatric dialysis patients.
    Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia; Infant; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Retrospective Studies; Treatment Outcome

2010
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
    The New England journal of medicine, 2012, Dec-27, Volume: 367, Issue:26

    Topics: Adult; Aged; Cardiovascular Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Intention to Treat Analysis; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Odds Ratio; Parathyroid Hormone; Renal Dialysis

2012

Other Studies

29 other study(ies) available for cinacalcet and Hypocalcemia

ArticleYear
AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia.
    International journal of molecular sciences, 2022, Apr-13, Volume: 23, Issue:8

    Topics: Calcium; Cinacalcet; Humans; Hypocalcemia; Male; Neuroblastoma; Receptors, Calcium-Sensing

2022
Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism.
    World journal of surgery, 2023, Volume: 47, Issue:8

    Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies; Treatment Outcome

2023
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.
    Jornal brasileiro de nefrologia, 2019, Jul-18, Volume: 41, Issue:3

    Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D

2019
Lessons learned from the management of Hungry Bone Syndrome following the removal of an Atypical Parathyroid Adenoma.
    Journal of musculoskeletal & neuronal interactions, 2019, 09-01, Volume: 19, Issue:3

    Topics: Adenoma; Adult; Bone Density Conservation Agents; Calcium; Calcium-Regulating Hormones and Agents; Cholecalciferol; Cinacalcet; Humans; Hydroxycholecalciferols; Hyperparathyroidism; Hypocalcemia; Hypophosphatemia; Magnesium; Male; Parathyroid Neoplasms; Parathyroidectomy; Postoperative Complications; Syndrome

2019
Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes.
    Journal of nephrology, 2020, Volume: 33, Issue:4

    Topics: Aged; Calcium; Cinacalcet; Europe; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis

2020
Dialysate calcium concentration during calcimimetic treatment: a neglected issue.
    Journal of nephrology, 2021, Volume: 34, Issue:1

    Topics: Calcium; Cinacalcet; Dialysis Solutions; Humans; Hypocalcemia; Renal Dialysis

2021
Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism.
    Renal failure, 2018, Volume: 40, Issue:1

    Topics: Aged; Calcimimetic Agents; Calcium; Cinacalcet; Cross-Sectional Studies; Female; Gallstones; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Prevalence; Renal Dialysis; Sex Factors; Time Factors

2018
Facing cinacalcet-induced hypocalcemia: sit back and relax?
    Kidney international, 2018, Volume: 93, Issue:6

    Topics: Bone and Bones; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Naphthalenes; Parathyroid Hormone; Renal Dialysis

2018
Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic-pharmacodynamic analysis of cinacalcet.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:6

    Topics: Adolescent; Adult; Age Factors; Biomarkers; Calcimimetic Agents; Child; Child, Preschool; Cinacalcet; Computer Simulation; Drug Dosage Calculations; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Models, Biological; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome

2019
Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption.
    JCI insight, 2019, 04-23, Volume: 5

    Topics: Animals; Calcimimetic Agents; Calcium; Calcium Channels; Cinacalcet; Disease Models, Animal; Estrenes; Female; Gene Knock-In Techniques; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Intestinal Absorption; Intestinal Mucosa; Kidney Tubules; Male; Mice; Mice, Transgenic; Oocytes; Parathyroid Hormone; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrrolidinones; Receptors, Calcium-Sensing; TRPV Cation Channels; Type C Phospholipases; Xenopus

2019
Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:3

    Topics: Animals; Calcium; Cinacalcet; Claudins; Epigenesis, Genetic; Gene Expression Regulation; Histone Deacetylase Inhibitors; Hypercalciuria; Hypocalcemia; Hypoparathyroidism; Kidney; Magnesium; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Naphthalenes; Receptors, Calcium-Sensing

2015
Cinacalcet-associated severe hypocalcemia resulting in torsades de pointes and cardiac arrest: a case for caution.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:3

    Topics: Adult; Calcimimetic Agents; Cinacalcet; Heart Arrest; Humans; Hypocalcemia; Kidney Failure, Chronic; Male; Torsades de Pointes

2016
Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
    The Journal of biological chemistry, 2016, May-13, Volume: 291, Issue:20

    Topics: Allosteric Regulation; Amino Acid Substitution; Cinacalcet; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Hypercalcemia; Hypocalcemia; Mutation, Missense; Naphthalenes; Receptors, Calcium-Sensing; Signal Transduction

2016
Optimal TARGETs for cardiovascular safety and benefit in ESRD.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:10

    Topics: Calcium; Cardiovascular Diseases; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Safety; Sterols; Vitamin D

2008
Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009, Volume: 53, Issue:2

    Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Phosphorus

2009
Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?
    Nature reviews. Nephrology, 2009, Volume: 5, Issue:6

    Topics: Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis

2009
Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of cinacalcet.
    The American surgeon, 2009, Volume: 75, Issue:9

    Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Incidence; Male; Naphthalenes; Parathyroidectomy; Postoperative Complications; Retrospective Studies; Treatment Outcome

2009
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
    American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:6

    Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia

2010
Do calcimimetics directly alter bone remodeling?
    American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:6

    Topics: Animals; Biomarkers; Bone Remodeling; Bone Resorption; Calcitriol; Cinacalcet; Ergocalciferols; Fibroblast Growth Factors; Humans; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Parathyroid Hormone; Rats; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Treatment Outcome; Uremia

2010
The bone and mineral disorder of children undergoing chronic peritoneal dialysis.
    Kidney international, 2010, Volume: 78, Issue:12

    Topics: Adolescent; Calcium; Child; Child, Preschool; Cinacalcet; Europe; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Hypocalcemia; Infant; Kidney Failure, Chronic; Latin America; Male; Naphthalenes; North America; Parathyroid Hormone; Peritoneal Dialysis; Phosphate-Binding Proteins; Phosphorus; Prospective Studies; Registries; Vitamin D; Young Adult

2010
[Potentialisation of hyperkalemia effects by cinacalcet-induced hypocalcemia on dialysis].
    Nephrologie & therapeutique, 2012, Volume: 8, Issue:6

    Topics: Adult; Cinacalcet; Electrocardiography; Female; Humans; Hyperkalemia; Hypocalcemia; Male; Middle Aged; Naphthalenes; Renal Dialysis

2012
Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism.
    Langenbeck's archives of surgery, 2013, Volume: 398, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Transplantation; Length of Stay; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Preoperative Care; Retrospective Studies; Thyroidectomy

2013
Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.
    Clinical endocrinology, 2013, Volume: 79, Issue:1

    Topics: Aged; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Primary; Hypocalcemia; Italy; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Product Surveillance, Postmarketing; Retrospective Studies; Time Factors; Treatment Outcome

2013
[The influence of side effects related to cinacalcet therapy on compliance in hemodialysis patients suffering from secondary hyperparathyroidism].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:3

    Topics: Administration, Oral; Adult; Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Muscle Weakness; Naphthalenes; Parathyroid Hormone; Paresthesia; Patient Compliance; Renal Dialysis

2012
Cinacalcet (sensipar).
    The Medical letter on drugs and therapeutics, 2004, Sep-27, Volume: 46, Issue:1192

    Topics: Cinacalcet; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Fees, Pharmaceutical; Hypocalcemia; Naphthalenes; Nausea; Vomiting

2004
Calcimimetics for predialysis patients?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:1

    Topics: Calcifediol; Chronic Disease; Cinacalcet; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphates; Vitamin D; Vitamin D Deficiency

2006
Hypophosphatemia and hungry bone syndrome in a dialysis patient with secondary hyperparathyroidism treated with cinacalcet--proposal for an improved monitoring.
    Clinical laboratory, 2006, Volume: 52, Issue:11-12

    Topics: Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia; Middle Aged; Naphthalenes; Phosphates; Renal Dialysis

2006
Cinacalcet modifies the pH of solutions in vitro: possible implications for gastro-intestinal side effects in vivo.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:8

    Topics: Cinacalcet; Gastrointestinal Tract; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism; Hypocalcemia; Male; Middle Aged; Naphthalenes; Renal Dialysis; Spectrophotometry; Time Factors

2007
Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:7

    Topics: Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Prospective Studies; Recurrence; Retreatment; Treatment Outcome

2007